Pharmaceuticals
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Trend Stats
1-Month Return
+3.62%
3-Month Return
+13.57%
12-Month Return
+38.38%
Volatility Score
1.8
RSI
60.0
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Pharmaceuticals
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +95.31% | +30.11% | +3.65% | 3.3 | Up | Up |
| JNJ | Johnson&Johnson | $631B | +54.38% | +18.98% | +1.88% | 2.3 | Up | Up |
| ABBV | AbbVie | $438B | +28.71% | +23.91% | +0.67% | 2.6 | Up | Up |
| MRK | Merck | $323B | +69.06% | +18.39% | +5.97% | 2.5 | Up | Up |
| NVS | Novartis Sp ADR | $298B | +36.25% | +7.37% | +1.78% | 2.1 | Neutral | Up |
| AZN | ASTRAZENECA | $251B | +11.17% | -10.86% | -5.02% | 2.7 | Down | Down |
| NVO | Nordisk Sp ADR-B | $209B | +0.17% | +3.60% | -3.54% | 3.4 | Neutral | Up |
| PFE | Pfizer | $154B | +17.77% | +7.18% | +13.87% | 1.9 | Up | Up |
| BMY | Bristol-MyersSqu | $132B | +47.95% | +16.76% | +12.61% | 2.9 | Up | Up |
| GSK | GSK Sp ADR | $104B | +43.52% | +4.40% | -1.17% | 2.5 | Neutral | Neutral |
| SNY | SANOFI SP ADR | $104B | -2.80% | +0.39% | -0.05% | 2.2 | Neutral | Down |
| MCK | Mckesson | $103B | +31.32% | +19.67% | +9.17% | 3.2 | Up | Up |
| COR | Cencora | $62B | +12.64% | +24.77% | +7.11% | 2.5 | Up | Neutral |
| TAK | TAKEDA PHARM SP ADR | $56B | +26.50% | +6.62% | +5.98% | 2.1 | Up | Up |
| HLN | Haleon Sp ADR | $44B | +6.93% | +9.00% | +1.74% | 2.2 | Up | Neutral |
| TEVA | TEVAPHARMIND SP ADR | $42B | +120.10% | +1.15% | +9.68% | 3.1 | Up | Up |
| ZTS | Zoetis-A | $31B | -48.82% | -9.03% | -0.28% | 3.7 | Down | Down |
| VTRS | Viatris | $19B | +71.62% | -4.49% | +0.06% | 3.4 | Down | Up |
| JAZZ | Jazz Pharmaceuti | $17B | +131.62% | +13.61% | +5.21% | 2.8 | Up | Up |
| CORT | Corcept Therapeu | $12B | +58.72% | +118.50% | +24.33% | 5.1 | Up | Up |
| AXSM | Axsome Therapeut | $11B | +112.48% | +1.61% | -5.52% | 4.3 | Down | Up |
| ELAN | ELANC ANIML HLTH | $11B | +30.29% | -5.79% | -10.23% | 5.1 | Down | Down |
| OGN | Organon | $3.6B | +52.50% | +2.18% | +0.74% | 0.3 | Neutral | Up |
| BHC | BAUSCH HEALTH | $2.4B | -4.65% | +10.43% | +32.85% | 5.6 | Up | Up |
| PRGO | Perrigo | $1.8B | -37.69% | +10.75% | +23.68% | 4.9 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |